TETRAULT LYNN A. 4

What Happened

• Lynn A. Tetrault, a director of Neogenomics, reported the sale of 5,307 shares of NEO common stock on June 9, 2026. The shares were disposed at $11.29 each, for total proceeds of $59,916. This was a sale (routine insider disposition), not a purchase.

Key Details

• Transaction date: 2026-06-09
• Transaction type/code: Sale (S) — reported as open-market/private sale
• Price per share: $11.29
• Total proceeds: $59,916
• Shares owned after transaction: Not disclosed in the provided filing excerpt
• Footnote: F1 — once vested, the shares of common stock are not subject to expiration
• Filing timeliness: Report filed on 2026-06-11 (filed within the typical two-business-day Form 4 window)

Context

• Sales by directors can be routine (diversification, liquidity, tax planning) and do not necessarily indicate a change in outlook. Because this filing reports a sale rather than a purchase, it is less commonly interpreted as a bullish signal.